Clinical Trial: Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508254) titled 'Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome' on March 27.

Brief Summary: The goal of this clinical trial is to evaluate whether triple lipid-lowering therapy (atorvastatin, ezetimibe, and bempedoic acid) is more effective than dual therapy (atorvastatin and ezetimibe) in reducing LDL cholesterol levels in adults with acute coronary syndrome. It will also assess the safety of the treatment.

The main questions it aims to answer are:

* Does triple therapy result in greater reduction in LDL-C compared to dual therapy?

* What adverse effects occur in participants receiving triple therapy?

Rese...